Asia Pacific Oncology Companion Diagnostic Market Size & Outlook
Asia Pacific oncology companion diagnostic market, 2018-2030 (US$M)
Asia Pacific oncology companion diagnostic market highlights
- The Asia Pacific oncology companion diagnostic market generated a revenue of USD 874.2 million in 2023.
- The market is expected to grow at a CAGR of 11.4% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 874.2 million |
| Market revenue in 2030 | USD 1,857.1 million |
| Growth rate | 11.4% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | Agilent Technologies Inc, Illumina Inc, Qiagen NV, Thermo Fisher Scientific Inc, Roche, ARUP Laboratories, Abbott Laboratories, Myriad Genetics Inc, BioMerieux SA |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.3% of the global oncology companion diagnostic market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,857.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oncology Companion Diagnostic Market Scope
Oncology Companion Diagnostic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific oncology companion diagnostic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology companion diagnostic market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 66.51% in 2023. Horizon Databook has segmented the Asia Pacific oncology companion diagnostic market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific market is expected to witness substantial growth driven by healthcare reforms, enhanced infrastructure, a growing population, and an increasing number of local companies entering the market. With a large population and high cancer prevalence, the region is a significant focus for oncology advancements.
According to Global Cancer Statistics 2022, nearly half of all global cancer cases and approximately 56.1% of cancer deaths in 2022 were reported in Asia. In addition, GLOBOCAN data indicates that Asia Pacific accounted for the highest share of global cancer incidences in 2022, representing 45.5%, with a total of 232,537 cases.
The favorable growth conditions in the Asia Pacific region, including healthcare improvements and market entry by local companies, are likely to drive the demand for companion diagnostics. The high cancer prevalence and incidence underscore the need for effective diagnostic solutions, making the region a key market for oncology companion diagnostics.
Reasons to subscribe to Asia Pacific oncology companion diagnostic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific oncology companion diagnostic market databook
-
Our clientele includes a mix of oncology companion diagnostic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific oncology companion diagnostic market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific oncology companion diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific oncology companion diagnostics market size, by country, 2018-2030 (US$M)
Asia Pacific Oncology Companion Diagnostic Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
